Shop by goal

  • Metabolic Research
  • GH-Axis Research
  • Muscle & IGF Research
  • Tissue and Cellular Models
  • Regenerative Research
  • Cellular Senescence Research
  • Cognitive Research
  • Multi-Compound Blends
  • Accessories
  • All compounds →
  • Popular compounds

  • BPC-157
  • TB-500
  • GHK-Cu
  • GLP1-RC-RT
  • GLP1-RC-SM
  • Ipamorelin
  • All bestsellers →
  • Research resources

  • Research Glossary
  • Peptide Guides
  • Delivery Guide
  • Track Order
  • Recently viewed

  • Peptide 101
  • Research Areas
  • Peptide Blog
  • Community Forum
  • Crypto Blog
  • Research Glossary
  • Reconstitution Calculator
  • Peptide Tracker
  • Research Protocol Tools
  • Peptide Guides
  • Sign In
  • Create Account
  • Track My Order
  • Refer a Friend
  • My Account
  • My Orders
  • My Referrals
  • Log Out
  • How-to guides

    CJC-1295 (No DAC) + Ipamorelin Blend peptide: Stacks research guide

    In short: CJC-1295 (no DAC) and ipamorelin in one vial at a fixed 1:1 ratio, in two strengths: 5 mg + 5 mg and 10 mg + 10 mg per vial. A GHRH analogue paired with a selective ghrelin-receptor agonist. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.

    Not medical advice. CJC-1295 (No DAC) + Ipamorelin Blend is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

    CJC-1295 (No DAC) + Ipamorelin Blend at a glance

    Compound type
    Research peptide
    Research category
    Stacks
    Also known as
    CJC-1295 no DAC ipamorelin blend, Mod GRF 1-29 ipamorelin, CJC/Ipa blend, Mod GRF 1-29 plus ghrelin-receptor agonist, CP10, CP20
    Evidence context
    Preclinical / research use only
    Regulatory status
    Not an approved medicine. Supplied as a research compound
    Last reviewed
    14 October 2026

    What to know first

    Compound CJC-1295 (No DAC) + Ipamorelin Blend Research class Stacks Catalog code CP10 Available pack sizes 10 × 10 mg, 10 × 20 mg Storage Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.

    Details and limits sit in the sections below. Research use only. No unsupported scientific claims are added here.

    What CJC-1295 (No DAC) + Ipamorelin Blend is

    A fixed 1:1 research blend of CJC-1295 (no DAC) and ipamorelin, offered at 5 mg + 5 mg and 10 mg + 10 mg per vial: a growth-hormone-releasing-hormone analogue and a selective ghrelin-receptor agonist in one vial.

    One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.

    CJC-1295 (no DAC) and ipamorelin in one vial at a fixed 1:1 ratio, in two strengths: 5 mg + 5 mg and 10 mg + 10 mg per vial. A GHRH analogue paired with a selective ghrelin-receptor agonist.

    Research contexts

    Peer-reviewed papers discuss CJC-1295 (No DAC) + Ipamorelin Blend in specific lab settings. The points below reflect research questions, not health claims.

    Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.

    Typical study contexts

  • Component peptides are usually characterised individually first; combination papers are less common.
  • Two growth-hormone-axis research peptides pre-combined at a fixed 1:1 ratio.
  • Two vial strengths in one product: 5 + 5 mg and 10 + 10 mg.
  • CJC-1295 (no DAC): tetrasubstituted GHRH(1-29) analogue acting on the GHRH receptor.
  • Ipamorelin: pentapeptide characterised as a selective growth hormone secretagogue.
  • Why Stacks research matters

    Stack products combine research peptides. Guides note how components are usually studied alone first.

    Mechanisms (technical review)

    Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.

  • Two growth-hormone-axis research peptides pre-combined at a fixed 1:1 ratio
  • Two vial strengths in one product: 5 + 5 mg and 10 + 10 mg
  • CJC-1295 (no DAC): tetrasubstituted GHRH(1-29) analogue acting on the GHRH receptor
  • Ipamorelin: pentapeptide characterised as a selective growth hormone secretagogue
  • Two different receptors on the same cell type, the usual reason the pair is studied together
  • Both compounds are also sold on their own, so the blend can be benchmarked against its parts
  • Lab handling & preparation

  • Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.. See the storage guide.
  • Published pharmacokinetic context: Laboratory research material. No amount, schedule or administration guidance is published or recommended on this page.
  • Purity check: Use the COA reading guide and the published Certificates of Analysis (no current certificate is listed for CJC-1295 (No DAC) + Ipamorelin Blend yet).
  • Common Questions People Are Asking

    What is in the CJC-1295 (No DAC) + Ipamorelin Blend?

    Each vial holds CJC-1295 without DAC and ipamorelin in a fixed 1:1 ratio: 5 mg of each (10 mg per vial, code CP10) or 10 mg of each (20 mg per vial, code CP20). Choose the strength from the pack-size menu.

    Why are the two compounds paired?

    They act on the same pituitary cell type through different receptors: CJC-1295 on the GHRH receptor and ipamorelin on a ghrelin-type receptor. That is the rationale for studying them together. This page cites no study of the fixed blend itself.

    Is this the same as CJC-1295 with DAC?

    No. The DAC form carries an albumin-binding group and acts for days; the no-DAC form in this vial does not. The human study in the references used the DAC form, so its results are not findings about this blend.

    Is there a Certificate of Analysis for this blend?

    Not yet. No independent analytical report has been published for this material, so no purity figure is quoted. If one is published it will appear on this page and on our COA page.

    Is there human data on this blend?

    No study of the blend is cited. This is laboratory research material, sold strictly for in-vitro and preclinical research and not for human or veterinary use.

    Is this page medical advice? Can I use CJC-1295 (No DAC) + Ipamorelin Blend for my health?

    No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

    Where do I find CJC-1295 (No DAC) + Ipamorelin Blend specs, purity certificates and pricing?

    Open the shop listing via “View product details.” There you will see concentration, purity grade, and available SKUs with current pricing. No current Certificate of Analysis is published for CJC-1295 (No DAC) + Ipamorelin Blend yet; published certificates are listed at /coa.

    Related peptide guides

    Other compounds researchers often read about alongside CJC-1295 (No DAC) + Ipamorelin Blend.

  • CJC-1295 (without DAC): HGH / Somatropin research guide
  • Ipamorelin: HGH / Somatropin research guide
  • CJC-1295 (with DAC): HGH / Somatropin research guide
  • Sermorelin: HGH / Somatropin research guide
  • Tesamorelin + Ipamorelin Blend: Stacks research guide
  • Continue CJC-1295 (No DAC) + Ipamorelin Blend research

    Analytical evidence, comparisons and current research for this compound. Research use only.

  • Research area Growth hormone secretagogue research The GH-axis research area - GHRH analogues and ghrelin-receptor agonists studied for their effect on pulsatile growth-hormone secretion. Explore the research area →
  • Related research CJC-1295 & ipamorelin: a research guide to the GHRH + GHRP pair The most-studied GHRH + GHRP research combination. CJC-1295 with DAC vs no-DAC explained, ipamorelin’s selective ghrelin-receptor… Read the article →
  • Scientific sources & further reading

    Primary literature and registries for CJC-1295 (No DAC) + Ipamorelin Blend, plus mainstream coverage of the peptide category. Research use only - not medical advice.

    Databases & literature:

  • PubMed: peer-reviewed literature on CJC-1295 + Ipamorelin Blend
  • ClinicalTrials.gov: registered studies on CJC-1295 + Ipamorelin Blend
  • CJC-1295 + Ipamorelin Blend: Wikipedia (search)
  • Peptides in the news:

  • WebMD: consumer health reference
  • BBC News: Health
  • CNN Health: “Peptides: what to know about the wellness trend”
  • Sky News: “Can peptides make America healthy again?”
  • Sky News: “Inside the exploding US peptides craze” (video)
  • Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”
  • Sky News Australia: “Backyard peptide boom sparks alarm” (video)
  • Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”
  • Ready to order? View full product specs

    Access concentration, batch info, variants, and current pricing on our shop.

    Also known as: CJC-1295 no DAC ipamorelin blend, Mod GRF 1-29 ipamorelin, CJC/Ipa blend, Mod GRF 1-29 plus ghrelin-receptor agonist, CP10, CP20

    PRECISION. PURITY. PERFORMANCE.

    Research peptides. Third-party Certificates of Analysis (Janoshik Analytical & Freedom Diagnostics) are published on the website. Supplied strictly for laboratory research use.

    Shop

  • All research compounds
  • Price list
  • Where to buy peptides
  • Compare compounds
  • Compare vial sizes
  • Affiliate programme
  • Research

  • Peptide 101
  • Published COAs
  • Research areas
  • Research blog
  • How-to guides
  • Peptide guides
  • Research glossary
  • Support

  • Track your order
  • Contact us
  • Shipping & delivery
  • International shipping
  • FAQ
  • Community forum
  • Refund policy
  • Ways to Pay

  • Google Pay
  • Apple Pay
  • Venmo
  • Cryptocurrency
  • Crypto wallets
  • Cash App
  • Card payments
  • Bank transfer (SEPA)
  • Paying with crypto
  • Live crypto prices
  • Shop by goal

  • Metabolic Research
  • GH-Axis Research
  • Muscle & IGF Research
  • Tissue and Cellular Models
  • Regenerative Research
  • Cellular Senescence Research
  • Cognitive Research
  • Multi-Compound Blends
  • Accessories
  • Shop by compound

  • BPC-157
  • TB-500
  • GHK-Cu
  • Tesamorelin
  • Retatrutide
  • Semaglutide
  • Tirzepatide
  • CJC-1295 (without DAC)
  • All compounds →
  • Shop by region
  • United Kingdom
  • United States
  • Australia
  • Canada
  • Canada (FR)
  • Ireland
  • Northern Ireland
  • Malta
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Portugal
  • Greece
  • Austria
  • Poland
  • Sweden
  • Finland
  • Denmark
  • Norway
  • Croatia
  • Slovakia
  • Slovenia
  • Estonia
  • Latvia
  • Lithuania
  • Czechia
  • Hungary
  • Romania
  • Bulgaria
  • Belgium
  • Belgium (FR)
  • Luxembourg
  • Deutsch
  • Ελληνικά
  • Español
  • Français
  • Italiano
  • Research use only - all claims made on this site are for testing and research use only. Purchasers must be 21 years of age or older.

    All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.

    Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

    Principal office: 1712 Pioneer Ave., Ste. 500, Cheyenne, WY 82001, USA

    © 2026 New-U Research Compounds · new-u.io

    [image: New-U Research Compounds on PepFinder, live PepFinder store rating]

    Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.

    © 2026 New-U Research Compounds · new-u.io — Copyright held with Hilxera Distribution Services LLC. All rights reserved.